Results 71 to 80 of about 28,111,627 (303)

Experience With Pretravel Testing for SARS-CoV-2 at an Academic Medical Center

Academic Pathology, 2021
International travel has been a significant factor in the coronavirus disease 2019 pandemic. Many countries and airlines have implemented travel restrictions to limit the spread of the causative agent, severe acute respiratory syndrome coronavirus-2.
Katherine L. Imborek MD, Matthew D. Krasowski MD, PhD, Paul Natvig MD, Anna E. Merrill PhD, Daniel J. Diekema MD, Bradley A. Ford MD, PhD   +5 more
doaj   +1 more source

Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report

Journal of Medical Case Reports, 2021
Background The topic of natural immunity related to severe acute respiratory syndrome coronavirus 2 remains controversial. Although evidence suggests postinfection immunity can be achieved, there have been reported cases of reinfection with similar or ...
Nimrah Bader, Mahmood Khattab, Fahmi Farah   +2 more
doaj   +1 more source

Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus [PDF]

Journal of General Virology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged to cause widespread infections in humans. SARS-CoV-2 infections have been reported in the Kingdom of Saudi Arabia, where Middle East respiratory syndrome coronavirus (MERS-CoV) causes seasonal outbreaks with a case fatality rate of ~37 %.
Banerjee, Arinjay, Doxey, Andrew C., Tremblay, Benjamin J.-M., Mansfield, Michael J., Subudhi, Sonu, Hirota, Jeremy A., Miller, Matthew S., McArthur, Andrew G., Mubareka, Samira, Mossman, Karen   +9 more
openaire   +2 more sources

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, Dominick J. Angiolillo   +3 more
doaj   +1 more source

Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2

Archives of Medical Research, 2020
What began with a sign of pneumonia-related respiratory disorders in China has now become a pandemic named by WHO as Covid-19 known to be caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The SARS-CoV-2 are newly emerged β coronaviruses belonging to the Coronaviridae family.
Satarker, Sairaj, Nampoothiri, Madhavan
openaire   +2 more sources

Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium

Journal of Virology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds.
Milewska, Aleksandra, Kula-Pacurar, Anna, Wadas, Jakub, Suder, Agnieszka, Szczepanski, Artur, Dabrowska, Agnieszka, Owczarek, Katarzyna, Marcello, Alessandro, Ochman, Marek, Stacel, Tomasz, Rajfur, Zenon, Sanak, Marek, Labaj, Pawel, Branicki, Wojciech, Pyrc, Krzysztof   +14 more
openaire   +5 more sources

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

FEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes, Guilherme M. Azevedo, Amanda P. Barcellos, Diana Bahia   +3 more
wiley   +1 more source

Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report

Journal of Medical Case Reports, 2021
Background Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function.
Astrid Muyldermans, Piet Maes, Tony Wawina-Bokalanga, Tine Anthierens, Olivier Goldberg, Magali Bartiaux, Oriane Soetens, Ingrid Wybo, Sigi Van den Wijngaert, Denis Piérard   +9 more
doaj   +1 more source

Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China

Emerging Infectious Diseases, 2021
To limit the spread of severe acute respiratory syndrome coronavirus 2, the government of China has been monitoring infected travelers and minimizing cold-chain contamination. However, other factors might contribute to recurring outbreaks. We analyze the
Meiling Zhang, Jienan Zhou, Senquan Jia, Xiaonan Zhao, Yaoyao Chen, Yanhong Sun, Zhaosheng Liu, Xiaofang Zhou, Duo Li, Chunrui Luo, Yong Zhang, Violet Magoma Onsongo, Yong Shao, Xiaoqing Fu   +13 more
doaj   +1 more source

Methods for estimating the case fatality ratio for a novel, emerging infectious disease. [PDF]

, 2005
During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated. The authors propose a novel method for doing so based on the Kaplan-Meier survival procedure, jointly considering two ...
W. S. Chan, A. J. Hedley, Donnelly, CA, T. H. Lam, Hedley, AJ, A. C. Ghani, L. M. Ho, C. A. Donnelly, D. R. Cox, C. Fraser, G. M. Leung, Ho, LM, Ghani, AC, Anderson, RM, Cox, DR, Lam, TH, Griffin, JT, Leung, GM, Fraser, C, Chan, WS, J. T. Griffin, R. M. Anderson   +21 more
core   +1 more source